KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to $26.8 billion.

  • Bausch Health Companies' Liabilities and Shareholders Equity rose 107.01% to $26.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $107.0 billion, marking a year-over-year decrease of 24.6%. This contributed to the annual value of $26.5 billion for FY2024, which is 302.38% down from last year.
  • Latest data reveals that Bausch Health Companies reported Liabilities and Shareholders Equity of $26.8 billion as of Q3 2025, which was up 107.01% from $27.3 billion recorded in Q2 2025.
  • In the past 5 years, Bausch Health Companies' Liabilities and Shareholders Equity ranged from a high of $30.2 billion in Q1 2021 and a low of $25.4 billion during Q1 2023
  • Its 5-year average for Liabilities and Shareholders Equity is $27.4 billion, with a median of $26.9 billion in 2024.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first soared by 7732820.51% in 2021, then plummeted by 1253.01% in 2023.
  • Bausch Health Companies' Liabilities and Shareholders Equity (Quarter) stood at $29.2 billion in 2021, then dropped by 12.04% to $25.7 billion in 2022, then grew by 6.48% to $27.4 billion in 2023, then decreased by 3.02% to $26.5 billion in 2024, then grew by 1.13% to $26.8 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $26.8 billion for Q3 2025, versus $27.3 billion for Q2 2025 and $26.4 billion for Q1 2025.